JOHNSON & JOHNSON
CIK
200406
Location
NEW BRUNSWICK, NJ
Portfolio Value
Small
$798,649,907
Diversification
Moderately concentrated
Reports for
Johnson & Johnson Innovation - JJDC, Inc.
Filing Date
Global Rank
#2,891
/ 8,795
▼ 72
· as of Jun 2026
Top Industry
Biotechnology
94.9%
Period ended 3 months ago
Filed Aug 6, 2026 · 2mo
20 quarters · since Sep 2021
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
15 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
37.6%
−2.0 pts
Top 5
88.7%
−0.7 pts
Top 10
98.4%
−0.6 pts
HHI
2,370
Moderately concentrated−115
Portfolio Trend
20 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 98.5% | $786,807,401 |
| Technology | 1.5% | $11,842,506 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CBRS | Cerebras Systems Inc. | 53,586 | $11,842,506 | |
| No positions match the current search. | ||||
15 tracked positions ·
$798,649,907 total
· filing declares
15 positions · $798,650,757
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 2,449,183 | $300,220,852 | 37.59% | |
| NBTX |
Nanobiotix S.A.
Healthcare
|
Held | 5,623,816 | $212,017,863 | 26.55% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Held | 6,641,064 | $89,720,774 | 11.23% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 1,784,517 | $74,360,823 | 9.31% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Held | 1,979,173 | $32,438,645 | 4.06% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Held | 814,586 | $23,525,243 | 2.95% | |
| CVRX |
CVRx, Inc.
Healthcare
|
Held | 4,024,861 | $20,687,785 | 2.59% | |
| XNCR |
Xencor Inc
Healthcare
|
Held | 748,062 | $12,043,798 | 1.51% | |
| CBRS |
Cerebras Systems Inc.
Technology
|
NEW | 53,586 | $11,842,506 | 1.48% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Held | 3,379,064 | $9,123,472 | 1.14% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Held | 357,939 | $8,082,262 | 1.01% | |
| NMRA |
Neumora Therapeutics, Inc.
Healthcare
|
Held | 1,849,445 | $3,144,056 | 0.39% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 53,732 | $989,206 | 0.12% | |
| LAB |
Standard Biotools Inc.
Healthcare
|
Held | 311,967 | $255,812 | 0.03% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Held | 22,779 | $196,810 | 0.02% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.